Leadership with scientific depth
Meet the management team and scientific advisors guiding GlycoSeLect’s development and international growth.
Management
Robert Dunne
Chief Executive Officer
B.A. (Mod.), MBA, MICI
Robert is an experienced executive with over 34 years of experience in the pharmaceutical industry, with expertise in business development, operations, regulatory and quality management. He is responsible for the overall management and strategic direction of the company.
Dr Ian Evetts
Director
PhD
Ian has over 20 years' experience in the pharmaceutical industry, gained through senior positions in business development, licensing, sales and marketing across multinational companies and biotech organisations.
Neil Brown
Non-Executive Director
Neil has been a Non-Executive Director of GlycoSeLect for the past 8 years and has over 20 years' experience across banking, state agencies, manufacturing, distribution and services. His background includes corporate finance, mergers and acquisitions, insolvency and restructuring.
Song Zhiyang
China Representative
Song represents GlycoSeLect in China and has 20 years of working experience within the Chinese pharmaceutical industry, including multinational companies and R&D pharmaceutical associations. Based in Beijing, he supports the introduction of GlycoSeLect's RPL glycan-specific technology to glycobiology researchers.
Scientific Advisory Board
A group of scientific advisors supporting GlycoSeLect's strategic and technical direction.
Ready to discuss your glycan target or purification workflow?
Contact GlycoSeLect to explore RPL products for glycoanalysis, glycoprotein detection, separation and purification.